We’re excited to share GALVmed’s 2025 Year in Review, an overview of our accomplishments and the progress made throughout the year in advancing our mission. The review reflects a year […]
Small-scale livestock producers across sub-Saharan Africa continue to operate in an increasingly complex environment. Disease pressures remain high, climate variability is intensifying risk, and public animal health systems are often […]
GALVmed has officially launched its new 5-year programme, Veterinary Innovations Transforming Animal health & Livelihoods (VITAL 2) in Nigeria and Kenya. The new programme will leverage public and private partnerships […]
On 15th October 2025, as part of the Food and Agriculture Organization’s (FAO) 80th anniversary celebrations and on the occasion of the World Food Forum, the AgResults Foot and Mouth […]
At the recently held FAO 2025 Global Conference on Sustainable Livestock transformation, GALVmed participated in a side event titled “Tackling Tick and Acaricide Resistance through Surveillance and Diagnostics – From local […]
On Friday, 1st August 2025, Prof. Barnabas Nawangwe, Vice Chancellor of Makerere University, officially inaugurated the newly upgraded Research Centre for Tropical Diseases and Vector Control (RTC) Lab at the College of […]
Whilst the burden of human sleeping sickness has been reduced by more than 95%, Nagana – caused by different species of trypanosomes- continues to undermine livestock productivity across vast swathes […]
We’re excited to share GALVmed’s 2024 Year in Review. From product and market development to strategic partnerships and regulatory progress, this comprehensive report highlights the milestones and achievements that shaped […]
GALVmed is excited to announce the search for a new Chief Executive Officer as current CEO, Carolin Schumacher, prepares to step down later this year after providing exceptional leadership and […]
The control of Foot and Mouth Disease (FMD) in the Eastern Africa Region is now a step closer thanks to a newly registered first ever quadrivalent FMD vaccine tailored for […]
